News

News

Hikma licenses Chiesi Group’s respiratory and neonatal products for Egyptian market

News

News

Hikma and Arecor announce exclusive agreement to develop and commercialise ready-to-use medicine using Arestat™ technology

Find out more

Who we are. We make high quality medicines and make them accessible to the people that need them.

Our impact

The impact we have on people's lives is important, positive and far-reaching, listen to the stories of people whose lives we touch.

Case study

Case study

Our support and impact for the Healthy Kitchen Project

Case study

Case study

Our support and impact; improving patient’s access to ritonavir

News

News

Hikma provides an update on the status of its ANDA for generic Advair Diskus®

Case study

Case study

Medicine donations put better health in reach for patients in need

Hikma in the news

Hikma in the news

Siggi Olafsson interview with the Times London

News

News

Civica Rx and Hikma announce shipments of Heparin and seven other essential injectable medicines

Find out more

Find out more

Our commitment to sustainability

Find out more

Find out more

We develop, manufacture and market nearly 700 quality branded and non-branded generic medicines worldwide.